A Study Investigating the Association of Dermatological and Infusion Reactions to Infliximab and Infliximab Trough Levels

BACKGROUND: Although infliximab is an effective therapy for inflammatory bowel disease (IBD), it is associated with dermatological events and infusion reactions. It is not known whether a relationship between these adverse events (AEs) and infliximab trough levels (ITLs) exists.

Bibliographic Details
Main Authors:	Vivian Wai-Mei Huang, Neil Dhami, Darryl Fedorak, Connie Prosser, Carol Shalapay, Karen Ivy Kroeker, Brendan Phillip Halloran, Levinus Albert Dieleman, Richard Neil Fedorak
Format:	Article
Language:	English
Published:	Hindawi Limited 2015-01-01
Series:	Canadian Journal of Gastroenterology and Hepatology
Online Access:	http://dx.doi.org/10.1155/2015/428702

id	doaj-7fb919bec55d4ed5a6770c3fcb2db2cc
record_format	Article
spelling	doaj-7fb919bec55d4ed5a6770c3fcb2db2cc2020-11-24T23:20:55ZengHindawi LimitedCanadian Journal of Gastroenterology and Hepatology2291-27892291-27972015-01-01291354010.1155/2015/428702A Study Investigating the Association of Dermatological and Infusion Reactions to Infliximab and Infliximab Trough LevelsVivian Wai-Mei Huang0Neil Dhami1Darryl Fedorak2Connie Prosser3Carol Shalapay4Karen Ivy Kroeker5Brendan Phillip Halloran6Levinus Albert Dieleman7Richard Neil Fedorak8Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Alberta, CanadaDivision of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Alberta, CanadaDivision of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Alberta, CanadaDivision of Medical Biochemistry, Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, CanadaDivision of Medical Biochemistry, Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, CanadaDivision of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Alberta, CanadaDivision of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Alberta, CanadaDivision of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Alberta, CanadaDivision of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Alberta, CanadaBACKGROUND: Although infliximab is an effective therapy for inflammatory bowel disease (IBD), it is associated with dermatological events and infusion reactions. It is not known whether a relationship between these adverse events (AEs) and infliximab trough levels (ITLs) exists.http://dx.doi.org/10.1155/2015/428702
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Vivian Wai-Mei Huang Neil Dhami Darryl Fedorak Connie Prosser Carol Shalapay Karen Ivy Kroeker Brendan Phillip Halloran Levinus Albert Dieleman Richard Neil Fedorak
spellingShingle	Vivian Wai-Mei Huang Neil Dhami Darryl Fedorak Connie Prosser Carol Shalapay Karen Ivy Kroeker Brendan Phillip Halloran Levinus Albert Dieleman Richard Neil Fedorak A Study Investigating the Association of Dermatological and Infusion Reactions to Infliximab and Infliximab Trough Levels Canadian Journal of Gastroenterology and Hepatology
author_facet	Vivian Wai-Mei Huang Neil Dhami Darryl Fedorak Connie Prosser Carol Shalapay Karen Ivy Kroeker Brendan Phillip Halloran Levinus Albert Dieleman Richard Neil Fedorak
author_sort	Vivian Wai-Mei Huang
title	A Study Investigating the Association of Dermatological and Infusion Reactions to Infliximab and Infliximab Trough Levels
title_short	A Study Investigating the Association of Dermatological and Infusion Reactions to Infliximab and Infliximab Trough Levels
title_full	A Study Investigating the Association of Dermatological and Infusion Reactions to Infliximab and Infliximab Trough Levels
title_fullStr	A Study Investigating the Association of Dermatological and Infusion Reactions to Infliximab and Infliximab Trough Levels
title_full_unstemmed	A Study Investigating the Association of Dermatological and Infusion Reactions to Infliximab and Infliximab Trough Levels
title_sort	study investigating the association of dermatological and infusion reactions to infliximab and infliximab trough levels
publisher	Hindawi Limited
series	Canadian Journal of Gastroenterology and Hepatology
issn	2291-2789 2291-2797
publishDate	2015-01-01
description	BACKGROUND: Although infliximab is an effective therapy for inflammatory bowel disease (IBD), it is associated with dermatological events and infusion reactions. It is not known whether a relationship between these adverse events (AEs) and infliximab trough levels (ITLs) exists.
url	http://dx.doi.org/10.1155/2015/428702
work_keys_str_mv	AT vivianwaimeihuang astudyinvestigatingtheassociationofdermatologicalandinfusionreactionstoinfliximabandinfliximabtroughlevels AT neildhami astudyinvestigatingtheassociationofdermatologicalandinfusionreactionstoinfliximabandinfliximabtroughlevels AT darrylfedorak astudyinvestigatingtheassociationofdermatologicalandinfusionreactionstoinfliximabandinfliximabtroughlevels AT connieprosser astudyinvestigatingtheassociationofdermatologicalandinfusionreactionstoinfliximabandinfliximabtroughlevels AT carolshalapay astudyinvestigatingtheassociationofdermatologicalandinfusionreactionstoinfliximabandinfliximabtroughlevels AT karenivykroeker astudyinvestigatingtheassociationofdermatologicalandinfusionreactionstoinfliximabandinfliximabtroughlevels AT brendanphilliphalloran astudyinvestigatingtheassociationofdermatologicalandinfusionreactionstoinfliximabandinfliximabtroughlevels AT levinusalbertdieleman astudyinvestigatingtheassociationofdermatologicalandinfusionreactionstoinfliximabandinfliximabtroughlevels AT richardneilfedorak astudyinvestigatingtheassociationofdermatologicalandinfusionreactionstoinfliximabandinfliximabtroughlevels AT vivianwaimeihuang studyinvestigatingtheassociationofdermatologicalandinfusionreactionstoinfliximabandinfliximabtroughlevels AT neildhami studyinvestigatingtheassociationofdermatologicalandinfusionreactionstoinfliximabandinfliximabtroughlevels AT darrylfedorak studyinvestigatingtheassociationofdermatologicalandinfusionreactionstoinfliximabandinfliximabtroughlevels AT connieprosser studyinvestigatingtheassociationofdermatologicalandinfusionreactionstoinfliximabandinfliximabtroughlevels AT carolshalapay studyinvestigatingtheassociationofdermatologicalandinfusionreactionstoinfliximabandinfliximabtroughlevels AT karenivykroeker studyinvestigatingtheassociationofdermatologicalandinfusionreactionstoinfliximabandinfliximabtroughlevels AT brendanphilliphalloran studyinvestigatingtheassociationofdermatologicalandinfusionreactionstoinfliximabandinfliximabtroughlevels AT levinusalbertdieleman studyinvestigatingtheassociationofdermatologicalandinfusionreactionstoinfliximabandinfliximabtroughlevels AT richardneilfedorak studyinvestigatingtheassociationofdermatologicalandinfusionreactionstoinfliximabandinfliximabtroughlevels
_version_	1725573746994970624

A Study Investigating the Association of Dermatological and Infusion Reactions to Infliximab and Infliximab Trough Levels

Similar Items